| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/08/1997 | EP0751782A1 Methods for altering fertility |
| 01/08/1997 | EP0751709A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 01/08/1997 | CN1139933A Interleukin-6 (iL-6) antagonists |
| 01/07/1997 | US5591840 Antisense oligonucleotides directed against nucleic acids encoding NFKB transcription factor |
| 01/07/1997 | US5591721 Orally administering oligonucleotide with phosphorothioate internucleoside linkage |
| 01/07/1997 | US5591720 Oligonucleotides for modulating the effects of cytomegalovirus infections |
| 01/07/1997 | US5591624 Retroviral packaging cell lines |
| 01/07/1997 | US5591623 Oligonucleotide modulation of cell adhesion |
| 01/07/1997 | US5591600 Antisense inhibitors of the human immunodeficiency virus |
| 01/03/1997 | WO1997000326A1 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 01/03/1997 | WO1997000323A1 Adenovirus e1a-associated protein bs69, inhibitor of e1a-transactivation |
| 01/03/1997 | WO1997000241A1 New cationic and polycationic amphiphiles, reactives containing the same and their use |
| 01/03/1997 | WO1997000083A1 Method of treating cd4+ t cell lymphopenia in immuno-compromised patients |
| 01/03/1997 | CA2224566A1 New cationic and polycationic amphiphiles, reagents containing them and their use |
| 01/02/1997 | EP0750679A1 Isolated, tyrosinase derived peptides and uses thereof |
| 01/02/1997 | EP0750677A1 Process for treating eucaryotic cells |
| 01/02/1997 | EP0750676A1 Recombinant adenoviruses coding for brain-derived neurotrophic factor (bdnf) |
| 01/02/1997 | EP0750675A1 RECOMBINANT ADENOVIRUSES CODING FOR ACIDIC FIBROBLAST GROWTH FACTOR (aFGF) |
| 01/02/1997 | EP0750674A1 RECOMBINANT ADENOVIRUSES FOR GLIAL MATURATION FACTOR BETA (GMF-$g(b)) |
| 01/02/1997 | EP0750668A1 NOVEL MUTEINS OF IFN-$g(b) |
| 01/02/1997 | EP0750637A1 Dna encoding cai resistance proteins and uses thereof |
| 01/02/1997 | EP0750628A1 Fibroblast growth factor-10 |
| 01/02/1997 | EP0750626A1 Corpuscles of stannius protein, stanniocalcin |
| 01/02/1997 | EP0750516A1 Method of inhibiting the proliferation and causing the differentiation of cells with igf-1 receptor antisense oligonucleotides |
| 01/02/1997 | EP0750503A1 Ribozyme therapy for restenosis |
| 01/02/1997 | EP0750457A1 Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells |
| 01/02/1997 | EP0556345B1 Retroviral vectors useful for gene therapy |
| 01/02/1997 | EP0552178B1 Modified ribozymes |
| 12/31/1996 | US5589466 Induction of a protective immune response in a mammal by injecting a DNA sequence |
| 12/31/1996 | US5589374 Diabetogene rad: a type II diabetes specific gene |
| 12/31/1996 | US5589369 Cells homozygous for disrupted target loci |
| 12/31/1996 | US5589362 Fusion proteins, eukaryotic cells |
| 12/31/1996 | US5589358 Ileal bile acid transporter compositions and methods |
| 12/31/1996 | US5589341 Origin of replication complex genes and methods of using the same |
| 12/31/1996 | US5589154 Diagnosing presence of b-amyloid peptide |
| 12/27/1996 | WO1996041880A1 Adherence gene from helicobacter pylori and polypeptide coded thereby |
| 12/27/1996 | WO1996041873A1 Dry powder formulations of polynucleotide complexes |
| 12/27/1996 | WO1996041865A1 Rapamcycin-based regulation of biological events |
| 12/27/1996 | WO1996041606A2 Improved pharmaceutical compositions for gene therapy |
| 12/27/1996 | WO1996031607A3 Use of an 'immunodeficiency-virus suppressing lymphokine (isl)' to inhibit the replication of viruses, in particular of retroviruses |
| 12/27/1996 | WO1996021731A3 Stabilized external guide sequences |
| 12/27/1996 | EP0750044A2 DNA constructs and transfection of cells therewith for homologous recombination |
| 12/27/1996 | EP0750039A1 Immunoregulatory protein LST-1 |
| 12/27/1996 | EP0749496A1 Human dna mismatch repair proteins |
| 12/27/1996 | EP0749495A1 Nucleic acid mutation detection in histologic tissue |
| 12/27/1996 | EP0749484A1 COORDINATE $i(IN VIVO) GENE EXPRESSION |
| 12/27/1996 | EP0749477A1 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 12/27/1996 | EP0749472A1 Extracorporeal cell culture and transplantation kits |
| 12/27/1996 | EP0749442A1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES |
| 12/27/1996 | EP0664833B1 Therapeutic anti-hiv oligonucleotide and pharmaceutical |
| 12/27/1996 | CA2253496A1 Adherence gene from helicobacter pylori and polypeptide coded thereby |
| 12/27/1996 | CA2224156A1 Dry powder formulations of polynucleotide complexes |
| 12/27/1996 | CA2224146A1 Improved pharmaceutical compositions for gene therapy |
| 12/27/1996 | CA2219080A1 Rapamycin-based regulation of biological events |
| 12/25/1996 | CN1138865A Peptides and methods against psoriasis |
| 12/24/1996 | US5587470 3-deazapurines |
| 12/24/1996 | US5587469 Oligonucleotides containing N-2 substituted purines |
| 12/24/1996 | US5587308 Modified adeno-associated virus vector capable of expression from a novel promoter |
| 12/24/1996 | US5587306 Dna sequences |
| 12/24/1996 | US5587289 Isolated nucleic acid molecules which are members of the MAGE-Xp family and uses thereof |
| 12/19/1996 | WO1996041191A1 Methods and uses for apoptin |
| 12/19/1996 | WO1996040977A1 Origin of replication complex genes |
| 12/19/1996 | WO1996040965A1 Synthetic mammalian chromosome and methods for construction |
| 12/19/1996 | WO1996040964A2 Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer |
| 12/19/1996 | WO1996040963A1 Cationic lipid:dna complexes for gene targeting |
| 12/19/1996 | WO1996040962A1 Cationic lipid:dna complexes for gene targeting |
| 12/19/1996 | WO1996040961A1 Peptide-enhanced cationic lipid transfections |
| 12/19/1996 | WO1996040959A1 Cell line producing analgesic compounds for treating pain |
| 12/19/1996 | WO1996040958A1 Nucleic acid transporters for delivery of nucleic acids into a cell |
| 12/19/1996 | WO1996040955A1 Adenovirus vectors for gene therapy |
| 12/19/1996 | WO1996040954A1 Oral delivery of adeno-associated viral vectors |
| 12/19/1996 | WO1996040953A1 Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
| 12/19/1996 | WO1996040952A1 Plasmid for delivery of nucleic acids to cells and methods of use |
| 12/19/1996 | WO1996040948A2 RESISTANCE TO VIRUSES AND VIROIDS IN TRANSGENIC PLANT AND ANIMAL HOSTS EXPRESSING dsRNA-BINDING PROTEIN |
| 12/19/1996 | WO1996040945A2 Nucleic acid respiratory syncytial virus vaccines |
| 12/19/1996 | WO1996040929A2 Transferrin receptor genes |
| 12/19/1996 | WO1996040913A1 A gene encoding a human reduced folate carrier (rfc) and methods for the treatment of methotrexate-resistant, transport-deficient cancer cells |
| 12/19/1996 | WO1996040911A1 Modified steroid hormones for gene therapy and methods for their use |
| 12/19/1996 | WO1996040908A1 OLIGONUCLEOTIDES SPECIFIC FOR CYTOKINE SIGNAL TRANSDUCER gp130 mRNA |
| 12/19/1996 | WO1996040906A1 Optimized minizymes and miniribozymes and uses thereof |
| 12/19/1996 | WO1996040898A1 Triple-helix forming oligonucleotides for targeted mutagenesis |
| 12/19/1996 | WO1996040894A1 Treatment of insulin resistance |
| 12/19/1996 | WO1996040892A1 Tetracycline regulated transcriptional modulators with altered dna binding specificities |
| 12/19/1996 | WO1996040887A1 Immunoprotective barrier for transplantation of cells |
| 12/19/1996 | WO1996040884A1 Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof |
| 12/19/1996 | WO1996040879A1 Dna cassettes for expression of lytic peptides in mammalian cells and transgenic organisms containing same |
| 12/19/1996 | WO1996040877A1 Immortalization and disimmortalization of cells |
| 12/19/1996 | WO1996040871A1 Bioartificial organs comprising open pored foam-like membranes |
| 12/19/1996 | WO1996040868A1 Essential oligonucleotides of vertebrate telomerase |
| 12/19/1996 | WO1996040864A1 A novel protein, faf1, which potentiates fas-mediated apoptosis and uses thereof |
| 12/19/1996 | WO1996040762A1 Monocyte chemotactic protein-4 |
| 12/19/1996 | WO1996040725A1 Phosphonic acid-based cationic lipids |
| 12/19/1996 | WO1996040724A1 Recombinational cloning using engineered recombination sites |
| 12/19/1996 | WO1996040719A1 Endothelial-monocyte activating polypeptide iii |
| 12/19/1996 | WO1996040715A1 Therapeutic oligonucleotides targeting the human mdr1 and mrp genes |
| 12/19/1996 | WO1996040711A1 Cross-linking oligonucleotides |
| 12/19/1996 | WO1996040709A1 Pna-dna chimeras and pna synthons for their preparation |
| 12/19/1996 | WO1996040284A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy |
| 12/19/1996 | WO1996040272A1 Aav transduction of myoblasts |
| 12/19/1996 | WO1996040271A1 Treatment of hemoglobinopathies |